Top Markets
Coin of the day
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc.

NBSE
Rang în acțiuni #39173
Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics,... Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics, Inc. is dedicated to pioneering therapeutic solutions for rare genetic disorders and various cancers stemming from aberrant genes. At the core of its approach is the proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform. This technology is being utilized to target ailments such as Huntington's disease (HD) and myotonic dystrophy, in addition to a broader spectrum of genetic conditions and applications within oncology. The company's leading therapeutic candidates encompass NT0100, a PATrOL-powered anti-gene therapy for Huntington's disease; NT0200, another PATrOL-enabled anti-gene solution for myotonic dystrophy type 1; and NT0300, a PATrOL-based treatment specifically engineered to address the mutated KRAS gene. NeuBase Therapeutics, Inc. maintains its headquarters in Pittsburgh, Pennsylvania.
Preț acțiune
$0.378
Ultima sincronizare: 2024-05-24
Capitalizare de piață
$618.41K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează NeuBase Therapeutics, Inc. (NBSE)

Categorie

Istoric dividende pentru NeuBase Therapeutics, Inc. (NBSE)
NeuBase Therapeutics, Inc. (simbol acțiune: NBSE) a efectuat un total de 0 plăți de dividende.
Suma tuturor dividendelor (ajustată pentru split-uri de acțiuni) este: 0.00
Randamentul dividendului (TTM): 0
Plăți de dividende pentru NeuBase Therapeutics, Inc. (NBSE) din 2026 până în 2026
Plăți anuale de dividende
An Dividend (ajustat pentru split de acțiuni) Schimbă
Nu sunt suficiente date pentru perioada selectată.
Lista tuturor plăților de dividende
An Dividend Schimbă
Nu sunt suficiente date pentru perioada selectată.
Dividende ale companiilor similare sau concurente
Companie Număr de plăți de dividende Țara
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
29.00%
BE